SRPT

Sarepta Therapeutics, Inc. News Headlines

$22.67
*  
0.38
 negative 
1.7%
Get SRPT Alerts
*Delayed - data as of Apr. 15, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    SRPT Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Sarepta Therapeutics To Present At Needham Conference ; Webcast At 12:10 PM ET
4/8/2014 11:10:00 AM - RTT News

Why Now Is The Time To Get Behind Sarepta Therapeutics
4/1/2014 2:41:00 AM - Seeking Alpha

Looking For Value Among Biotechs After Precipitous Declines In Stock Price
3/24/2014 12:26:00 PM - Seeking Alpha

Prosensa Rises on Encouraging Data - Analyst Blog
3/19/2014 5:20:01 PM - Zacks.com

Prosensa Shares Jump on 'Encouraging' Phase II Drug Study
3/17/2014 7:28:00 PM - Dow Jones Business News

On Sarepta's 2013 Results And Upcoming Events
3/4/2014 9:57:00 AM - Seeking Alpha

Sarepta Therap. To Present At Cowen & Co. Conference; Webcast At 9:20 AM ET
3/4/2014 8:20:00 AM - RTT News

Sector Update: Healthcare Shares Flat to Lower Pre-Market; Pacira Up 5% on Phase 3 Trial Meeting Endpoints
2/27/2014 9:26:00 AM - MT Newswires

Sector Update: Healthcare
2/27/2014 9:22:40 AM - MT Newswires

Earnings Reaction History: Sarepta Therapeutics, Inc., 50.0% Follow-Through Indicator, 8.6% Sensitive
2/27/2014 7:25:25 AM - MT Newswires

Sarepta (SRPT) Enters Overbought Territory - Tale of the Tape
2/26/2014 7:52:01 AM - Zacks.com

SRPT: Insiders vs. Shorts
2/25/2014 3:26:53 PM - BNK Invest

Chen Lin's Perfect Biotech Market Prescription: Buy Low, Sell High
2/21/2014 10:00:00 AM - Seeking Alpha

Do Away With The Pill-A-Day Biotech Model: Steve Brozak
2/7/2014 2:05:00 PM - Seeking Alpha

How Sarepta Trading Will Evolve
1/23/2014 5:56:00 AM - Seeking Alpha

Professional Investor Explains His 2 Largest Healthcare Holdings
1/22/2014 12:48:00 PM - Seeking Alpha

Professional Investor Explains His 2 Largest Healthcare Holdings
1/22/2014 9:50:00 AM - Seeking Alpha

Sarepta Therapeutics (SRPT) Soars: Stock Up 40.1% - Tale of the Tape
1/17/2014 10:39:01 AM - Zacks.com

Pre-Market Most Active for Jan 16, 2014 : BBY, BAC, C, BHP, JCP, FOX, RESI, SRPT, FB, AMRN, MU, DRYS
1/16/2014 9:39:56 AM - NASDAQ.com News

Sector Update: Healthcare Shares Flat Pre-Market; Sarepta Therapeutics Drops 6% as Citi Cuts Rating to Sell from Neutral
1/6/2014 9:32:27 AM - MT Newswires

Sector Update: Healthcare
1/6/2014 9:31:45 AM - MT Newswires

Jason Napodano Positions For 2014: Biotech M&A Growth Trend To Continue
12/31/2013 10:45:00 AM - Seeking Alpha

Eteplirsen's Competitive Advantage Is Setting Up Sarepta For 2014
12/25/2013 7:57:00 AM - Seeking Alpha

Sarepta Down on FDA's Response - Analyst Blog
11/13/2013 1:05:38 PM - Zacks.com

US Stocks Turn Lower Amid Dallas Fed Taper Talk; Earnings Disappoint
11/12/2013 10:11:00 AM - MT Newswires